Nils-Erik Heldin
Senior faculty administrator at Institutionen för immunologi, genetik och patologi; Administration
- Telephone:
- +46 18 471 46 79
- E-mail:
- nils-erik.heldin@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
More information is available to staff who log in.
Publications
Recent publications
- Inhibition of integrin alpha(V)beta(6) changes fibril thickness of stromal collagen in experimental carcinomas (2018)
- Increased Fibrosis and Interstitial Fluid Pressure in Two Different Types of Syngeneic Murine Carcinoma Grown in Integrin β3-Subunit Deficient Mice (2012)
- Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites (2011)
- Nuclear cysteine cathepsin variants in thyroid carcinoma cells (2010)
- Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas (2009)
All publications
Articles
- Inhibition of integrin alpha(V)beta(6) changes fibril thickness of stromal collagen in experimental carcinomas (2018)
- Increased Fibrosis and Interstitial Fluid Pressure in Two Different Types of Syngeneic Murine Carcinoma Grown in Integrin β3-Subunit Deficient Mice (2012)
- Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites (2011)
- Nuclear cysteine cathepsin variants in thyroid carcinoma cells (2010)
- Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas (2009)
- Diverse bone morphogenetic protein expression profiles and smad pathway activation in different phenotypes of experimental canine mammary tumors (2009)
- Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36 (2007)
- Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models (2007)
- Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma (2007)
- Dämpad inflammation gör kemoterapi effektivare (2007)
- 2-methoxyestradiol induces apoptosis in cultured human anaplastic thyroid carcinoma cells (2006)
- Inhibition of carcinoma cell-derived VEGF reduces inflammatory characteristics in xenograft carcinoma (2006)
- Differential effects of TGF-beta1 on telomerase activity in thyroid carcinoma cells (2005)
- Inhibition of TGF-beta modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma (2005)
- Induction of apoptosis or necrosis in human endometrium cancer cells by 2-methoxyestradiol. (2004)
- Transforming growth factor-beta1-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3 (2003)
- Hyaluronan content in experimental carcinoma is not correlated to interstitial fluid pressure. (2003)
- Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells (2002)
- Transforming growth factor-beta and epithelial growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. (2002)
- Follicular growth of a thyroid carcinoma cell line (KAT-4) with abnormal E-cadherin and impaired epithelial barrier. (2002)
- Epidermal growth factor receptor signaling activates Met in human anaplastic thyroid carcinoma cells (2000)
- Smad7 mediates TGF-beta-induced apoptosis in prostatic carcinoma cells. (2000)
- Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function. (1999)
- Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members (1998)